OTCMKTS:CCEL Cryo-Cell International Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cryo-Cell International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $6.13 +0.21 (+3.55%) (As of 06/28/2022 12:00 AM ET) Add Compare Share Today's Range$6.02▼$6.3150-Day Range$5.83▼$6.5852-Week Range$5.83▼$14.16Volume1,355 shsAverage Volume6,875 shsMarket Capitalization$51.82 millionP/E Ratio23.56Dividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Email Address CCEL Stock Forecast (MarketRank)Overall MarketRank™1.26 out of 5 starsAnalyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cryo-Cell International. Previous Next 4.0 Community Rank Outperform VotesCryo-Cell International has received 50 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCryo-Cell International has received 32 “underperform” votes. (Add your “underperform” vote.)Community SentimentCryo-Cell International has received 60.98% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cryo-Cell International and other stocks. Vote “Outperform” if you believe CCEL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CCEL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCryo-Cell International does not currently pay a dividend.Dividend GrowthCryo-Cell International does not have a long track record of dividend growth. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cryo-Cell International insiders have not sold or bought any company stock.Percentage Held by Insiders38.65% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.68% of the stock of Cryo-Cell International is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryo-Cell International is 23.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.03.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryo-Cell International is 23.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.50.Price to Book Value per Share RatioCryo-Cell International has a P/B Ratio of 12.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cryo-Cell International (OTCMKTS:CCEL)Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.Read More CCEL Stock News HeadlinesJune 16, 2022 | bizjournals.comLogistics firm picks Garner for 240K-square-foot warehouseJune 4, 2022 | americanbankingnews.comCryo-Cell International (OTCMKTS:CCEL) Stock Price Passes Below 200 Day Moving Average of $9.12April 15, 2022 | bizjournals.comWhy this German company is expanding in KnightdaleApril 13, 2022 | seekingalpha.comCRYO-CELL International GAAP EPS of $0.10, revenue of $7.26MApril 13, 2022 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial ResultsMarch 23, 2022 | bizjournals.comStem cell firm launching Durham facility to attract businessMarch 18, 2022 | morningstar.comCord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service | MorningstarMarch 16, 2022 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository ServiceMarch 9, 2022 | finance.yahoo.comCryo-Cell Shares Its 2021 Annual Letter to ShareholdersFebruary 22, 2022 | seekingalpha.comCRYO-CELL International GAAP EPS of $0.00, revenue of $28.9MFebruary 22, 2022 | finance.yahoo.comCryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021January 15, 2022 | nasdaq.comCryo-Cell International, Inc. Common Stock (CCEL)December 20, 2021 | benzinga.comHow 2020's Hottest IPOs Have Performed In 2021See More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CCEL CUSIPN/A CIK862692 Webwww.cryo-cell.com Phone(813) 749-2100Fax813-855-4745Employees83Year FoundedN/ACompany Calendar Last Earnings4/13/2022Today6/28/2022Fiscal Year End11/30/2022Profitability EPS (Most Recent Fiscal Year)$0.259990 Trailing P/E Ratio23.56 Forward P/E RatioN/A P/E GrowthN/ANet Income$2.08 million Net Margins7.59% Pretax Margin9.61% Return on Equity51.59% Return on Assets3.81% Debt Debt-to-Equity RatioN/A Current Ratio0.59 Quick Ratio0.54 Sales & Book Value Annual Sales$28.89 million Price / Sales1.79 Cash Flow$0.40 per share Price / Cash Flow15.18 Book Value$0.49 per share Price / Book12.50Miscellaneous Outstanding Shares8,460,000Free Float5,190,000Market Cap$51.82 million OptionableNot Optionable Beta0.58 Cryo-Cell International Frequently Asked Questions How has Cryo-Cell International's stock performed in 2022? Cryo-Cell International's stock was trading at $11.60 on January 1st, 2022. Since then, CCEL stock has decreased by 47.2% and is now trading at $6.1250. View the best growth stocks for 2022 here. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International, Inc. (OTCMKTS:CCEL) posted its quarterly earnings results on Wednesday, April, 13th. The company reported $0.10 earnings per share for the quarter. The company had revenue of $7.26 million for the quarter. Cryo-Cell International had a net margin of 7.59% and a trailing twelve-month return on equity of 51.59%. View Cryo-Cell International's earnings history. Who are Cryo-Cell International's key executives? Cryo-Cell International's management team includes the following people: Mr. David I. Portnoy, Chairman & Co-CEO (Age 59, Pay $1.22M)Mr. Mark L. Portnoy, Co-CEO & Director (Age 58, Pay $873.34k)Ms. Jill M. Taymans, CFO & VP of Fin. (Age 52, Pay $205.42k)Mr. Oleg Mikulinsky, Chief Information Officer (Age 49, Pay $326.35k)Dr. Joanne Kurtzberg M.D., Medical Director and Member of Medical & Scientific Advisory Board Who are some of Cryo-Cell International's key competitors? Some companies that are related to Cryo-Cell International include Caladrius Biosciences (CLBS), Greenbrook TMS (GBNH), Ontrak (OTRK), Marpai (MRAI), Curative Biotechnology (CUBT), Pacific Health Care Organization (PFHOD), Curative Biotechnology (CTYX), BioRestorative Therapies (BRTX), Pacific Health Care Organization (PFHO), Baudax Bio (BXRX), American Caresource (GNOW), Hybrid Energy (HYBE) and QMed (QMED). View all of CCEL's competitors. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Blockchain (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA). What is Cryo-Cell International's stock symbol? Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL." Who are Cryo-Cell International's major shareholders? Cryo-Cell International's stock is owned by many different retail and institutional investors. Top institutional shareholders include Iszo Capital Management LP (4.22%). Company insiders that own Cryo-Cell International stock include Brian L Sheehy, David Portnoy, George Gaines and Mark L Portnoy. View institutional ownership trends for Cryo-Cell International. Which institutional investors are selling Cryo-Cell International stock? CCEL stock was sold by a variety of institutional investors in the last quarter, including Iszo Capital Management LP. View insider buying and selling activity for Cryo-Cell International or view top insider-selling stocks. How do I buy shares of Cryo-Cell International? Shares of CCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cryo-Cell International's stock price today? One share of CCEL stock can currently be purchased for approximately $6.13. How much money does Cryo-Cell International make? Cryo-Cell International (OTCMKTS:CCEL) has a market capitalization of $51.82 million and generates $28.89 million in revenue each year. The company earns $2.08 million in net income (profit) each year or $0.259990 on an earnings per share basis. How many employees does Cryo-Cell International have? Cryo-Cell International employs 83 workers across the globe. How can I contact Cryo-Cell International? Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The official website for Cryo-Cell International is www.cryo-cell.com. The company can be reached via phone at (813) 749-2100, via email at [email protected], or via fax at 813-855-4745. This page (OTCMKTS:CCEL) was last updated on 6/29/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
